Work

[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].

Year: 2003

Type: article

Abstract: Withdrawal symptoms occurred in a male neonate after maternal use of venlafaxine for depression during pregnancy. The symptoms were restlessness, hypertonia, jitteriness, irritability and poor feeding. The diagnosis was confirmed by a temporary improvement after administration of a low dose (1 mg) of venlafaxine to the boy. Eventually the symptoms began to decline spontaneously, and ceased after 8 days. Exposure to venlafaxine and other antidepressants which inhibit serotonin reuptake during the third trimester of pregnancy carries the risk of a neonatal withdrawal syndrome.

Source: PubMed

Authors: B R Bloem, D W Roofthooft, G J Lammers, A J de Beaufort, O F Brouwer

Language: Dutch

Topic: Prenatal Substance Exposure Effects

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2417416190

FWCI: 2.582

Cites:

Cited by: 33

Related to: 10